The 20-Year Dog: Inside the Biotech Race to Pause the Canine Aging Clock

Two universities, the University of Washington and Texas A&M, are also studying dog aging and potential drugs to combat it. The Dog Aging Project is currently running the TRIAD clinical trial to test rapamycin in aging dogs. Funded by a 2024 grant from the National Institutes of Health, the study’s goal is to assess the effects of the drug on better heart health, improved mobility, prolonged cognitive function, and increased lifespan.